Back to Directory Linda Lambrecht Email linda.lambrecht@umassmed.edu Institution WNE Maternal Pediatric Adolescent AIDS CTU Title Clinical Laboratory Supervisor Request an Update Affiliated Studies P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents DAIDS Number 10037 Research Area Treatment Study Status Concluded P1114: Safety and Immunogenicity of an RSV Vaccine cps2 DAIDS Number 11948 Research Area Complications & Comorbidities Study Status Concluded P1022: PI Including vs. PI-Sparing Regimen in Women During Pregnancy DAIDS Number 10192 Research Area Other Study Status Concluded P1038: Safety of High Dose Lopinavir/Ritonavir with and without Saquinavir DAIDS Number 10045 Research Area Other Study Status Concluded P1045: Prevalence of Metabolic Abnormalities in Vertically HIV-infected Children DAIDS Number 10108 Research Area Other Study Status Concluded Show All
P1020A: A Phase I/II, Open-Label, Pharmacokinetic and Safety Study of a Novel Protease Inhibitor (BMS-232632, Atazanavir, ATV, Reyataz) in Combination Regimens in Antiretroviral Therapy (ART)-Naive and Experienced HIV-infected Infants, Children and Adolescents DAIDS Number 10037 Research Area Treatment Study Status Concluded
P1114: Safety and Immunogenicity of an RSV Vaccine cps2 DAIDS Number 11948 Research Area Complications & Comorbidities Study Status Concluded
P1022: PI Including vs. PI-Sparing Regimen in Women During Pregnancy DAIDS Number 10192 Research Area Other Study Status Concluded
P1038: Safety of High Dose Lopinavir/Ritonavir with and without Saquinavir DAIDS Number 10045 Research Area Other Study Status Concluded
P1045: Prevalence of Metabolic Abnormalities in Vertically HIV-infected Children DAIDS Number 10108 Research Area Other Study Status Concluded
